Adam Besnivick: How to Invest in Pre-Seed & Seed Stage Companies; Looking Glass Capital | E1020

Core Investment Philosophy:

• Identifies "winners" as adaptable entities and "losers" as those lacking distinct value.
• Views "reputation with founders" as the single most critical currency for an investor, strictly prioritizing it over transactional deal outcomes.
• Operates on the hypothesis that a sterling reputation compels higher-quality deal flow and better references over time.
• Prefers the mindset of "seeing an amazing company and passing on it" rather than missing out on a potential unicorn, shifting from "ignorance is bliss" to active selectivity.

Looking Glass Fund Strategy & Structure:

• Fund Size: Currently investing out of Fund II ($20M target), an iterative step up from Fund I ($8.5M).
• Check Size: Averages $400K–$500K, targeting 5.25%–5.5% average ownership (up from 4% in Fund I).
• Portfolio Size: Targets 27–30 companies per fund; Fund I held 24 companies.
• Valuation Strategy: Targets pre-seed/early seed rounds at $6M–$10M post-money caps, rarely exceeding $11M.
• Geographic Focus: Concentrates on secondary and tertiary hubs (Austin, Chicago, Boulder, Portland, Toronto, Boston, North Carolina) to maintain lower valuations; limited presence in SF/NYC.
• First-Money Principle: Strives to be the "First Yes" or lead investor, defining a "lead" as the party that sets terms and catalyzes the round rather than necessarily writing the largest check.
• Thematic Investing: Focuses exclusively on "mission-driven" sectors including healthcare, climate, education, and small business SaaS to constrain scope and build deep domain expertise.

Fundraising & LP Dynamics:

• LP Composition: Fund I comprised 80+ investors (mostly individuals/angel investors); Fund II shifts toward high-net-worth individuals and family offices.
• Minimum Check: $100K (Fund I) and $250K (Fund II), though exceptions are made for high-strategic-value LPs.
• Warm Intro Reliance: 100% of Fund I LPs were known personally; fundraising relies on warm introductions from existing LPs rather than cold outreach.
• Transparency Practices: Maintains a data room containing an investment memo for every deal and sends detailed eight-weekly letters to all LPs.
• Closing Strategy: Advises founders to secure a "first close" once 50% of the minimum viable fund size is committed to avoid over-capitalizing with a small portfolio.
• Urgency Mechanism: Demonstrates momentum through consistent updates, marking, and co-investor participation rather than artificial deadlines.

Founder Evaluation & Due Diligence:

• Founder Profiling: Prioritizes "mission-driven" entrepreneurs with unique operating experience or personal history in the sector, specifically seeking resilience against regulatory and legacy incumbent challenges.
• Financial Modeling: Generally rejects pre-revenue financial models, viewing them as unreliable; seeks only an understanding of business drivers and levers.
• Risk Management: Every investment memo includes a "Risks and Mitigants" slide; accepts that 40–50% of the portfolio may return zero or less than one-x, relying on the top 20–30% for fund returns.
• Lead Syndication: Acts as a placement agent post-commitment to curate syndicates, leveraging relationships with niche, thematic investors (e.g., Nashville-based healthcare investors) rather than just household names.
• Adverse Selection: Rejects the notion of adverse selection in small checks; believes founders actively select the GP based on thematic fit and value add.

Market Critique & Forward-Looking Statements:

• Market Cycle Analysis: Criticizes the 2021 "fervor" of rapid deployment, noting the current "whiplash" where VCs are slowing deal counts from ~50/year to ~8/year and hoarding dry powder for reserves.
• Seed vs. Series A: Observes that Seed is relatively immune to the downturn, while Series B/C/D is in a "death zone"; notes multi-stage firms moving down-market and over-capitalizing early rounds (e.g., $7.3M "seed" rounds).
• Capital Discipline: Advocates for founders to raise only enough capital for 24 months of gross burn, operating as if they raised half that amount to force PMF efficiency.
• Future of Venture (2028): Expects a bifurcation into specialized, vertical thematic funds and massive behemoths, with mid-sized firms struggling to compete.
• Industry Goal: Hopes for greater transparency and consistency in the fundraising process, viewing the current "dog and pony show" as unnecessarily opaque.
• Personal Evolution: Changed mindset in the last 12 months regarding "signaling," now prioritizing raising from reliable sources over the optics of specific investor names.

Specific Deal Examples & Outcomes:

• Fund I Performance: Average ownership at entry was ~4%; expects 60-65% dilution over the life of the fund, resulting in >1.5% ownership at a $1B exit (2x fund return).
• Portfolio Composition: 14 of 24 Fund I deals were led or co-led by Looking Glass; 10-11 deals had Bay Area ties, while others were in diverse hubs.
• Round Dynamics: Successfully led rounds where larger investors (e.g., General Catalyst, True Ventures) joined later without altering terms, proving small checks can coexist with larger institutional capital.
• Exception Handling: Adopts a strict rule-based approach where exceptions (e.g., slightly higher valuations) are only made if the deal reaches a level deemed previously unattainable, ensuring the exception is justified by extreme quality.

Advice to Founders:

• Investor Selection: Founders should diversify beyond "Midas List" names to include niche, thematic investors who offer specific industry value.
• Partner Fit: Emphasizes the importance of the specific partner, not just the fund entity, as personalities and internal dynamics dictate success.
• Cap Table Health: Warns against over-dilution at early stages; suggests that raising $5M at $25M pre-money creates a "target on your back" before product-market fit.
• Runway Planning: Advises founders to model cash flow to ensure they have at least seven months of cash remaining in January 2025 if no new fundraising occurs until then.